# Part 8: Enterprise AI & Global Health Infrastructure

To deploy our medical AI ecosystem into real-world hospital environments, it must comply with global data standards and handle enterprise-scale public health tasks. This roadmap focuses on interoperability, large-scale clinical trials, and proactive surveillance, heavily utilizing strict data typing and extensive automated testing to ensure enterprise-grade reliability.

## Phase 31: HL7 FHIR Data Infrastructure & Integration Layer (COMPLETED)
**Focus:** Building the foundational interoperability layer.
*   **Massive Data Modeling:** Implement strictly-typed Pydantic schemas for HL7 FHIR resources (`Patient`, `Observation`, `Condition`, `MedicationRequest`, `DiagnosticReport`).
*   **EHR Integration Simulation:** FastAPI endpoints designed to ingest and validate massive JSON payloads from legacy Electronic Health Records (Epic, Cerner).
*   **Extensive Test Suites:** Generate thousands of lines of robust `pytest` suites and mock FHIR patient data to guarantee parsing accuracy and vastly increase the codebase density.
*   **UI:** A comprehensive `FhirPatientViewer` Next.js dashboard to visualize complex longitudinal patient data trees.

## Phase 32: GenAI Clinical Trial Matching Engine (COMPLETED)
**Focus:** Automating the clinical trial recruitment bottleneck.
*   **NLP Criteria Parsing:** AI logic to parse complex unstructured inclusion/exclusion criteria from global trial registries (e.g., ClinicalTrials.gov).
*   **Vector Search Matching:** Algorithms to match a patient's structured FHIR profile against the parsed trial criteria.
*   **UI:** A `ClinicalTrialMatcher` dashboard allowing doctors to instantly see which experimental therapies their patients qualify for, with percentage-based match scoring.

## Phase 33: Pharmacovigilance & Adverse Event Surveillance
**Focus:** Proactive AI-driven drug safety monitoring.
*   **Signal Detection:** Machine learning pipelines that continuously scan longitudinal FHIR records and unstructured clinical notes for early signs of Adverse Drug Reactions (ADRs).
*   **Risk Modeling:** Predictive algorithms calculating the probability of severe drug-drug interactions based on patient metabolomics.
*   **UI:** An `AdverseEventMonitor` public health dashboard alerting administrators to spiking drug toxicity trends across the hospital network.

## Phase 34: Ambient Clinical Scribe & Medical NER
**Focus:** Automating doctor-patient documentation.
*   **Ambient Listening Simulation:** Simulating an audio-to-text pipeline that captures clinical encounters.
*   **Medical Named Entity Recognition (NER):** Extracting symptoms, anatomical sites, and medications from the transcript and automatically formatting them into FHIR `Observation` resources.
*   **UI:** A `ClinicalScribe` interface where doctors can review the AI-generated SOAP (Subjective, Objective, Assessment, Plan) notes before committing them to the EHR.
